Dr. Most on why Merck’s COVID-19 pill would be a game changer

Health

FILE – In this Dec. 18, 2014, file photo, a person walks through a Merck company building in Kenilworth, N.J. COVID-19 infections weighed Merck with so many people avoiding visits to hospitals or even the doctor early in the first quarter. The pharmaceutical company on Thursday, April 29, 2021, reported first-quarter earnings of $3.18 billion.(AP Photo/Mel Evans, File)

This week’s 9:30 Sunday morning COVID-19 segment features Dr. Kevin Most, Chief Medical Officer at Northwestern Central DuPage Hospital. Dr. Most says he has “local optimism” for COVID cases and says vaccinations numbers are up. Dean asks Dr. Most about the details on Merck’s new COVID-19 pills. Dr. Most answers calls and questions from listeners.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

COVID-19 risk as determined by nonprofit Covid Act Now.

Coronavirus Resources from the CDC

Dean Richards' Entertainment Report

More Dean Richards’ Entertainment Report

Popular